利尿薬の世界市場2022年-2026年

◆英語タイトル:Global Diuretic Drugs Market 2022-2026

Technavioが発行した調査報告書(IRTNTR73814-22)◆商品コード:IRTNTR73814-22
◆発行会社(リサーチ会社):Technavio
◆発行日:2022年6月26日
◆ページ数:約120
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、 ヨーロッパ、 アジア、その他地域
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥370,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Technavio社の最新調査レポートによると、世界の利尿薬市場規模は2022年から2026年までの間に年平均5.44%成長し、95.64百万ドルに達する見通しです。当書では、利尿薬の世界市場を広く調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、製品タイプ別(ループ利尿薬、チアジド系利尿薬、その他)分析、顧客状況、地域別状況、推進要因・課題・動向、企業状況、企業分析などの内容をまとめております。なお、本書に掲載されている企業情報には、AbbVie Inc.、Akorn Inc.、Alembic Pharmaceuticals Ltd.、Amneal Pharmaceuticals Inc.、Aurobindo Pharma Ltd.、Bausch Health Companies Inc.、Casper Pharma、Hikma Pharmaceuticals Plc、Lannett Co. Inc.、Monarch Pharmachemなどが含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・世界の利尿薬市場規模:製品タイプ別(ループ利尿薬、チアジド系利尿薬、その他)
・顧客状況
・地域別状況
・推進要因・課題・動向
・企業状況
・企業分析

Global Diuretic Drugs Market 2022-2026

Technavio has been monitoring the diuretic drugs market and it is poised to grow by $ 95.64 million during 2022-2026, accelerating at a CAGR of 5.44% during the forecast period. Our report on the diuretic drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of hypertension among people, increasing drug distribution through online channels, and increasing geriatric population.

The diuretic drugs market analysis includes the product type segment and geographic landscape.
Technavio’s diuretic drugs market is segmented as below:

By Product Type
• Loop diuretics
• Thiazide diuretics
• Others

By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing kidney diseases as one of the prime reasons driving the diuretic drugs market growth during the next few years. Also, the development of oral nanoparticle delivery mechanism and increased high investments in R&D activities in diuretics will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on diuretic drugs market covers the following areas:
• Diuretic drugs market sizing
• Diuretic drugs market forecast
• Diuretic drugs market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading diuretic drugs market vendors that include AbbVie Inc., Akorn Inc., Alembic Pharmaceuticals Ltd., Amneal Pharmaceuticals Inc., Aurobindo Pharma Ltd., Bausch Health Companies Inc., Casper Pharma, Hikma Pharmaceuticals Plc, Lannett Co. Inc., Monarch Pharmachem, Novartis AG, Padagis US LLC, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Validus Pharmaceuticals LLC, VITARIS AG, and Zydus Lifesciences Ltd. Also, the diuretic drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/diuretic-drugs-market-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Product Type
o Exhibit 06: Executive Summary – Chart on Incremental Growth
o Exhibit 07: Executive Summary – Data Table on Incremental Growth
o Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis – Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition – Five forces 2021 and 2026
• 5 Market Segmentation by Product Type
o 5.1 Market segments
o Exhibit 24: Chart on Product Type – Market share 2021-2026 (%)
o Exhibit 25: Data Table on Product Type – Market share 2021-2026 (%)
o 5.2 Comparison by Product Type
o Exhibit 26: Chart on Comparison by Product Type
o Exhibit 27: Data Table on Comparison by Product Type
o 5.3 Loop diuretics – Market size and forecast 2021-2026
o Exhibit 28: Chart on Loop diuretics – Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Loop diuretics – Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Loop diuretics – Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Loop diuretics – Year-over-year growth 2021-2026 (%)
o 5.4 Thiazide diuretics – Market size and forecast 2021-2026
o Exhibit 32: Chart on Thiazide diuretics – Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Thiazide diuretics – Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Thiazide diuretics – Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Thiazide diuretics – Year-over-year growth 2021-2026 (%)
o 5.5 Others – Market size and forecast 2021-2026
o Exhibit 36: Chart on Others – Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Others – Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Others – Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Others – Year-over-year growth 2021-2026 (%)
o 5.6 Market opportunity by Product Type
o Exhibit 40: Market opportunity by Product Type ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 44: Chart on Geographic comparison
o Exhibit 45: Data Table on Geographic comparison
o 7.3 North America – Market size and forecast 2021-2026
o Exhibit 46: Chart on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on North America – Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on North America – Year-over-year growth 2021-2026 (%)
o 7.4 Europe – Market size and forecast 2021-2026
o Exhibit 50: Chart on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Europe – Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Europe – Year-over-year growth 2021-2026 (%)
o 7.5 Asia – Market size and forecast 2021-2026
o Exhibit 54: Chart on Asia – Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Asia – Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Asia – Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) – Market size and forecast 2021-2026
o Exhibit 58: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o 7.7 US – Market size and forecast 2021-2026
o Exhibit 62: Chart on US – Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on US – Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on US – Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on US – Year-over-year growth 2021-2026 (%)
o 7.8 Denmark – Market size and forecast 2021-2026
o Exhibit 66: Chart on Denmark – Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Denmark – Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Denmark – Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Denmark – Year-over-year growth 2021-2026 (%)
o 7.9 China – Market size and forecast 2021-2026
o Exhibit 70: Chart on China – Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on China – Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on China – Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on China – Year-over-year growth 2021-2026 (%)
o 7.10 Canada – Market size and forecast 2021-2026
o Exhibit 74: Chart on Canada – Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Canada – Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Canada – Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Canada – Year-over-year growth 2021-2026 (%)
o 7.11 India – Market size and forecast 2021-2026
o Exhibit 78: Chart on India – Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on India – Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on India – Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on India – Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 82: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 AbbVie Inc.
o Exhibit 89: AbbVie Inc. – Overview
o Exhibit 90: AbbVie Inc. – Product / Service
o Exhibit 91: AbbVie Inc. – Key offerings
o 10.4 Alembic Pharmaceuticals Ltd.
o Exhibit 92: Alembic Pharmaceuticals Ltd. – Overview
o Exhibit 93: Alembic Pharmaceuticals Ltd. – Product / Service
o Exhibit 94: Alembic Pharmaceuticals Ltd. – Key offerings
o 10.5 Aurobindo Pharma Ltd.
o Exhibit 95: Aurobindo Pharma Ltd. – Overview
o Exhibit 96: Aurobindo Pharma Ltd. – Product / Service
o Exhibit 97: Aurobindo Pharma Ltd. – Key offerings
o 10.6 Hikma Pharmaceuticals Plc
o Exhibit 98: Hikma Pharmaceuticals Plc – Overview
o Exhibit 99: Hikma Pharmaceuticals Plc – Business segments
o Exhibit 100: Hikma Pharmaceuticals Plc – Key offerings
o Exhibit 101: Hikma Pharmaceuticals Plc – Segment focus
o 10.7 Novartis AG
o Exhibit 102: Novartis AG – Overview
o Exhibit 103: Novartis AG – Business segments
o Exhibit 104: Novartis AG – Key offerings
o Exhibit 105: Novartis AG – Segment focus
o 10.8 Pfizer Inc.
o Exhibit 106: Pfizer Inc. – Overview
o Exhibit 107: Pfizer Inc. – Product / Service
o Exhibit 108: Pfizer Inc. – Key news
o Exhibit 109: Pfizer Inc. – Key offerings
o 10.9 Sun Pharmaceutical Industries Ltd.
o Exhibit 110: Sun Pharmaceutical Industries Ltd. – Overview
o Exhibit 111: Sun Pharmaceutical Industries Ltd. – Product / Service
o Exhibit 112: Sun Pharmaceutical Industries Ltd. – Key offerings
o 10.10 Teva Pharmaceutical Industries Ltd.
o Exhibit 113: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 114: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 115: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 116: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 117: Teva Pharmaceutical Industries Ltd. – Segment focus
o 10.11 Validus Pharmaceuticals LLC
o Exhibit 118: Validus Pharmaceuticals LLC – Overview
o Exhibit 119: Validus Pharmaceuticals LLC – Product / Service
o Exhibit 120: Validus Pharmaceuticals LLC – Key offerings
o 10.12 VITARIS AG
o Exhibit 121: VITARIS AG – Overview
o Exhibit 122: VITARIS AG – Product / Service
o Exhibit 123: VITARIS AG – Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 124: Inclusions checklist
o Exhibit 125: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 126: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 127: Research methodology
o Exhibit 128: Validation techniques employed for market sizing
o Exhibit 129: Information sources
o 11.5 List of abbreviations
o Exhibit 130: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Product Type
Exhibits6: Executive Summary – Chart on Incremental Growth
Exhibits7: Executive Summary – Data Table on Incremental Growth
Exhibits8: Executive Summary – Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global – Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis – Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants – Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes – Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry – Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition – Five forces 2021 and 2026
Exhibits24: Chart on Product Type – Market share 2021-2026 (%)
Exhibits25: Data Table on Product Type – Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Product Type
Exhibits27: Data Table on Comparison by Product Type
Exhibits28: Chart on Loop diuretics – Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Loop diuretics – Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Loop diuretics – Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Loop diuretics – Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Thiazide diuretics – Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Thiazide diuretics – Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Thiazide diuretics – Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Thiazide diuretics – Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Others – Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Others – Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Others – Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Others – Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Product Type ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America – Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America – Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America – Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America – Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe – Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe – Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe – Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia – Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia – Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia – Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US – Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US – Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US – Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US – Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Denmark – Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Denmark – Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Denmark – Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Denmark – Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China – Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China – Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China – Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China – Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Canada – Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Canada – Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Canada – Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Canada – Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on India – Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on India – Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on India – Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on India – Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: AbbVie Inc. – Overview
Exhibits90: AbbVie Inc. – Product / Service
Exhibits91: AbbVie Inc. – Key offerings
Exhibits92: Alembic Pharmaceuticals Ltd. – Overview
Exhibits93: Alembic Pharmaceuticals Ltd. – Product / Service
Exhibits94: Alembic Pharmaceuticals Ltd. – Key offerings
Exhibits95: Aurobindo Pharma Ltd. – Overview
Exhibits96: Aurobindo Pharma Ltd. – Product / Service
Exhibits97: Aurobindo Pharma Ltd. – Key offerings
Exhibits98: Hikma Pharmaceuticals Plc – Overview
Exhibits99: Hikma Pharmaceuticals Plc – Business segments
Exhibits100: Hikma Pharmaceuticals Plc – Key offerings
Exhibits101: Hikma Pharmaceuticals Plc – Segment focus
Exhibits102: Novartis AG – Overview
Exhibits103: Novartis AG – Business segments
Exhibits104: Novartis AG – Key offerings
Exhibits105: Novartis AG – Segment focus
Exhibits106: Pfizer Inc. – Overview
Exhibits107: Pfizer Inc. – Product / Service
Exhibits108: Pfizer Inc. – Key news
Exhibits109: Pfizer Inc. – Key offerings
Exhibits110: Sun Pharmaceutical Industries Ltd. – Overview
Exhibits111: Sun Pharmaceutical Industries Ltd. – Product / Service
Exhibits112: Sun Pharmaceutical Industries Ltd. – Key offerings
Exhibits113: Teva Pharmaceutical Industries Ltd. – Overview
Exhibits114: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibits115: Teva Pharmaceutical Industries Ltd. – Key news
Exhibits116: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibits117: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibits118: Validus Pharmaceuticals LLC – Overview
Exhibits119: Validus Pharmaceuticals LLC – Product / Service
Exhibits120: Validus Pharmaceuticals LLC – Key offerings
Exhibits121: VITARIS AG – Overview
Exhibits122: VITARIS AG – Product / Service
Exhibits123: VITARIS AG – Key offerings
Exhibits124: Inclusions checklist
Exhibits125: Exclusions checklist
Exhibits126: Currency conversion rates for US$
Exhibits127: Research methodology
Exhibits128: Validation techniques employed for market sizing
Exhibits129: Information sources
Exhibits130: List of abbreviations



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 利尿薬の世界市場2022年-2026年(Global Diuretic Drugs Market 2022-2026)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆